Individualized Ofatumumab versus Fixed Low‐Dose Rituximab in MuSK‐Antibody‐Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study

Authors:
  • QZQian Zhou
    Qian Zhou
  • YZYi Zhong
    Yi Zhong
  • WYWeifan Yin
    Weifan Yin
  • FJFei Jiang
    Fei Jiang
  • QZQiuming Zeng
    Qiuming Zeng
  • GSGuanzhong Shi
    Guanzhong Shi
  • YOYuzhen Ouyang
    Yuzhen Ouyang
  • THTing He
    Ting He
  • XDXiaohua Dong
    Xiaohua Dong
  • ZWZeyi Wen
    Zeyi Wen
  • HCHaobing Cai
    Haobing Cai
  • WXWei Xiang
    Wei Xiang
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • Department of Science and Technology of Hunan Province (2024JK2115)
  • National Natural Science Foundation of China (82171399)
  • National Natural Science Foundation of China (82371413)
  • National Natural Science Foundation of China (82571597)

This publication has 34 references indexed in Scilit: